Xeris Biopharma Holdings Inc (XERS)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | ||||||
| Total Revenue | 25.31M | 29.73M | 33.14M | 33.2M | 38.01M | 48.32M | 44.39M | 40.64M |
| Operating Income | -18.92M | -18.78M | -15.17M | -13.28M | -15.98M | -4.91M | -9.84M | -14.25M |
| Pre Tax Income | -26.52M | -22.17M | -13.27M | -16.83M | -20.52M | -12.53M | -13.63M | -18.67M |
| Net Income | -26.19M | -21.83M | -12.93M | -16.83M | -19.84M | -12.19M | -13.39M | -18.98M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -23.79M | -18.66M | -10.76M | -11.92M | -15.2M | -3.98M | -7.71M | -13.57M |
| EBITDA | -15.85M | -15.71M | -12.09M | -10.2M | -12.88M | -1.81M | -6.78M | -11.21M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 49.59M | 110.25M | 163.91M |
| Operating Income | -115.16M | -81.94M | -44.01M |
| Pre Tax Income | -122.73M | -96.08M | -63.5M |
| Net Income | -122.73M | -94.66M | -62.26M |
| Preferred Dividends | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.983 | -0.695 | -0.451 |
| EBIT | -115.16M | -85.1M | -38.81M |
| EBITDA | -113.28M | -69.7M | -31.68M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
